 Jason Burdick
Concepts (751)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogels | 139 | 2025 | 675 | 27.400 |
Why?
| | Hyaluronic Acid | 78 | 2025 | 222 | 15.430 |
Why?
| | Tissue Engineering | 83 | 2025 | 418 | 13.890 |
Why?
| | Biocompatible Materials | 82 | 2025 | 423 | 13.420 |
Why?
| | Polymers | 43 | 2025 | 491 | 7.070 |
Why?
| | Tissue Scaffolds | 39 | 2025 | 209 | 6.910 |
Why?
| | Bioprinting | 12 | 2025 | 29 | 6.860 |
Why?
| | Printing, Three-Dimensional | 18 | 2025 | 94 | 5.410 |
Why?
| | Chondrogenesis | 24 | 2024 | 83 | 4.890 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 18 | 2017 | 76 | 4.870 |
Why?
| | Extracellular Matrix | 32 | 2025 | 527 | 4.610 |
Why?
| | Myocardial Infarction | 34 | 2023 | 1045 | 3.650 |
Why?
| | Cartilage | 15 | 2024 | 188 | 3.160 |
Why?
| | Materials Testing | 24 | 2025 | 357 | 2.920 |
Why?
| | Cross-Linking Reagents | 23 | 2025 | 212 | 2.760 |
Why?
| | Ventricular Remodeling | 20 | 2023 | 262 | 2.660 |
Why?
| | Delayed-Action Preparations | 13 | 2018 | 180 | 2.600 |
Why?
| | Myocardium | 20 | 2023 | 1002 | 2.570 |
Why?
| | Biomimetic Materials | 7 | 2024 | 72 | 2.560 |
Why?
| | Nanotubes | 9 | 2016 | 47 | 2.400 |
Why?
| | Mechanotransduction, Cellular | 12 | 2025 | 111 | 2.390 |
Why?
| | Drug Carriers | 9 | 2018 | 127 | 2.340 |
Why?
| | Cell Culture Techniques | 14 | 2024 | 363 | 2.300 |
Why?
| | Animals | 161 | 2025 | 36862 | 2.300 |
Why?
| | Nanofibers | 8 | 2021 | 21 | 2.230 |
Why?
| | Stem Cells | 15 | 2020 | 593 | 2.070 |
Why?
| | Light | 14 | 2018 | 382 | 2.060 |
Why?
| | Chondrocytes | 11 | 2021 | 213 | 1.940 |
Why?
| | Cartilage, Articular | 9 | 2021 | 309 | 1.890 |
Why?
| | Cell Adhesion | 22 | 2022 | 467 | 1.830 |
Why?
| | Drug Delivery Systems | 16 | 2021 | 362 | 1.800 |
Why?
| | Injections | 21 | 2023 | 183 | 1.780 |
Why?
| | Spheroids, Cellular | 6 | 2025 | 76 | 1.660 |
Why?
| | Cell Movement | 14 | 2024 | 969 | 1.660 |
Why?
| | Regeneration | 10 | 2019 | 195 | 1.600 |
Why?
| | Meniscus | 3 | 2023 | 21 | 1.570 |
Why?
| | beta-Cyclodextrins | 8 | 2025 | 28 | 1.560 |
Why?
| | Osteogenesis | 7 | 2021 | 187 | 1.530 |
Why?
| | Adhesives | 3 | 2022 | 14 | 1.450 |
Why?
| | Hepatic Stellate Cells | 3 | 2016 | 14 | 1.430 |
Why?
| | Cadherins | 4 | 2018 | 205 | 1.430 |
Why?
| | Cells, Cultured | 37 | 2023 | 4197 | 1.380 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 622 | 1.370 |
Why?
| | Absorbable Implants | 8 | 2015 | 35 | 1.350 |
Why?
| | Microspheres | 12 | 2014 | 137 | 1.340 |
Why?
| | Stem Cell Transplantation | 5 | 2018 | 177 | 1.330 |
Why?
| | Polyethylene Glycols | 20 | 2025 | 640 | 1.330 |
Why?
| | Cell Differentiation | 20 | 2023 | 1987 | 1.330 |
Why?
| | Mechanical Phenomena | 8 | 2018 | 84 | 1.310 |
Why?
| | Combinatorial Chemistry Techniques | 4 | 2018 | 17 | 1.300 |
Why?
| | Cellular Microenvironment | 6 | 2022 | 84 | 1.240 |
Why?
| | Swine | 20 | 2024 | 774 | 1.230 |
Why?
| | Antigens, CD | 3 | 2018 | 522 | 1.200 |
Why?
| | Glycerol | 4 | 2016 | 94 | 1.190 |
Why?
| | Biomedical Technology | 3 | 2020 | 43 | 1.150 |
Why?
| | Ventricular Function, Left | 14 | 2023 | 540 | 1.140 |
Why?
| | Elastomers | 5 | 2016 | 28 | 1.130 |
Why?
| | Peptides | 7 | 2018 | 982 | 1.130 |
Why?
| | Cell Lineage | 4 | 2021 | 348 | 1.120 |
Why?
| | Rheology | 11 | 2022 | 91 | 1.110 |
Why?
| | Biopolymers | 4 | 2024 | 31 | 1.100 |
Why?
| | Osteoblasts | 7 | 2008 | 126 | 1.100 |
Why?
| | Rats | 36 | 2025 | 5639 | 1.080 |
Why?
| | Cell Survival | 19 | 2018 | 1119 | 1.040 |
Why?
| | Myofibroblasts | 5 | 2021 | 126 | 1.030 |
Why?
| | Transforming Growth Factor beta3 | 4 | 2021 | 10 | 1.000 |
Why?
| | Infrared Rays | 4 | 2016 | 25 | 1.000 |
Why?
| | Chemokine CXCL12 | 4 | 2021 | 81 | 1.000 |
Why?
| | NIH 3T3 Cells | 10 | 2018 | 144 | 0.980 |
Why?
| | Bone Morphogenetic Protein 2 | 3 | 2015 | 66 | 0.980 |
Why?
| | Mice | 47 | 2025 | 17774 | 0.980 |
Why?
| | Photochemical Processes | 7 | 2024 | 108 | 0.970 |
Why?
| | Endothelial Cells | 7 | 2024 | 779 | 0.960 |
Why?
| | Porosity | 9 | 2022 | 99 | 0.960 |
Why?
| | Dimethylpolysiloxanes | 2 | 2017 | 9 | 0.960 |
Why?
| | Humans | 136 | 2025 | 137294 | 0.940 |
Why?
| | Regenerative Medicine | 6 | 2024 | 47 | 0.930 |
Why?
| | Methacrylates | 8 | 2016 | 116 | 0.910 |
Why?
| | Adamantane | 6 | 2025 | 18 | 0.900 |
Why?
| | Collagen | 9 | 2025 | 446 | 0.880 |
Why?
| | Guided Tissue Regeneration | 6 | 2015 | 13 | 0.850 |
Why?
| | Interleukin-10 | 5 | 2018 | 302 | 0.850 |
Why?
| | Rats, Sprague-Dawley | 19 | 2024 | 2486 | 0.830 |
Why?
| | Elastic Modulus | 12 | 2019 | 123 | 0.820 |
Why?
| | Esters | 4 | 2022 | 76 | 0.810 |
Why?
| | Signal Transduction | 10 | 2023 | 5078 | 0.800 |
Why?
| | Hyaluronan Receptors | 3 | 2019 | 103 | 0.790 |
Why?
| | Nanotechnology | 3 | 2014 | 126 | 0.760 |
Why?
| | Heart Ventricles | 8 | 2022 | 792 | 0.750 |
Why?
| | Endothelial Progenitor Cells | 5 | 2021 | 20 | 0.750 |
Why?
| | Tensile Strength | 13 | 2025 | 97 | 0.730 |
Why?
| | Oligopeptides | 5 | 2019 | 272 | 0.730 |
Why?
| | Stress, Mechanical | 12 | 2025 | 481 | 0.730 |
Why?
| | Neovascularization, Physiologic | 10 | 2019 | 178 | 0.720 |
Why?
| | Decanoates | 3 | 2010 | 4 | 0.710 |
Why?
| | Photochemistry | 11 | 2009 | 135 | 0.710 |
Why?
| | Fractures, Cartilage | 3 | 2015 | 4 | 0.710 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 3 | 2018 | 9 | 0.700 |
Why?
| | Cattle | 14 | 2019 | 981 | 0.660 |
Why?
| | Nerve Growth Factors | 4 | 2009 | 79 | 0.660 |
Why?
| | Biomechanical Phenomena | 17 | 2025 | 808 | 0.660 |
Why?
| | Lactic Acid | 8 | 2010 | 306 | 0.650 |
Why?
| | Skull | 4 | 2014 | 139 | 0.650 |
Why?
| | Precision Medicine | 3 | 2023 | 428 | 0.650 |
Why?
| | Polyethyleneimine | 2 | 2016 | 18 | 0.650 |
Why?
| | Biology | 1 | 2021 | 87 | 0.650 |
Why?
| | Cell Communication | 3 | 2019 | 315 | 0.650 |
Why?
| | Small Molecule Libraries | 2 | 2011 | 95 | 0.640 |
Why?
| | Nanocomposites | 2 | 2009 | 14 | 0.620 |
Why?
| | Fibrinogen | 2 | 2025 | 168 | 0.620 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2022 | 251 | 0.620 |
Why?
| | Polyphenols | 1 | 2018 | 18 | 0.600 |
Why?
| | RNAi Therapeutics | 1 | 2018 | 5 | 0.600 |
Why?
| | Sulfhydryl Compounds | 5 | 2022 | 191 | 0.590 |
Why?
| | Alginates | 3 | 2016 | 46 | 0.580 |
Why?
| | Peptide Hydrolases | 2 | 2018 | 111 | 0.570 |
Why?
| | Biodegradation, Environmental | 5 | 2012 | 86 | 0.570 |
Why?
| | Azo Compounds | 1 | 2018 | 30 | 0.570 |
Why?
| | Extracellular Vesicles | 4 | 2022 | 145 | 0.570 |
Why?
| | Phosphoproteins | 3 | 2017 | 338 | 0.570 |
Why?
| | Ink | 4 | 2021 | 10 | 0.550 |
Why?
| | Musculoskeletal System | 1 | 2018 | 48 | 0.550 |
Why?
| | Caprolactam | 1 | 2017 | 3 | 0.550 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2017 | 429 | 0.540 |
Why?
| | Cell Nucleus | 3 | 2017 | 617 | 0.530 |
Why?
| | Gels | 3 | 2019 | 82 | 0.520 |
Why?
| | Organoids | 3 | 2022 | 112 | 0.520 |
Why?
| | Transfection | 3 | 2016 | 947 | 0.520 |
Why?
| | Models, Cardiovascular | 6 | 2017 | 195 | 0.510 |
Why?
| | Liver Cirrhosis | 2 | 2016 | 316 | 0.510 |
Why?
| | Fibroblasts | 8 | 2025 | 993 | 0.500 |
Why?
| | Microscopy, Atomic Force | 5 | 2019 | 126 | 0.500 |
Why?
| | Cell Line | 11 | 2023 | 2841 | 0.490 |
Why?
| | Microscopy, Electron, Scanning | 9 | 2013 | 200 | 0.490 |
Why?
| | Shear Strength | 2 | 2015 | 67 | 0.490 |
Why?
| | Gene Silencing | 1 | 2016 | 195 | 0.490 |
Why?
| | Molecular Imprinting | 2 | 2015 | 4 | 0.490 |
Why?
| | Disease Models, Animal | 19 | 2021 | 4284 | 0.480 |
Why?
| | Intercellular Signaling Peptides and Proteins | 5 | 2019 | 382 | 0.480 |
Why?
| | Surface Properties | 10 | 2018 | 416 | 0.480 |
Why?
| | Chemotaxis | 2 | 2012 | 130 | 0.480 |
Why?
| | Osteoarthritis | 3 | 2024 | 185 | 0.480 |
Why?
| | Bone Regeneration | 1 | 2015 | 25 | 0.470 |
Why?
| | Polymethacrylic Acids | 2 | 2013 | 63 | 0.470 |
Why?
| | Acrylic Resins | 3 | 2025 | 46 | 0.470 |
Why?
| | RNA Interference | 1 | 2016 | 467 | 0.460 |
Why?
| | Magnetics | 1 | 2014 | 48 | 0.460 |
Why?
| | Genetic Therapy | 1 | 2016 | 296 | 0.450 |
Why?
| | Maleimides | 1 | 2014 | 23 | 0.450 |
Why?
| | Tibial Meniscus Injuries | 1 | 2015 | 48 | 0.450 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2014 | 15 | 0.440 |
Why?
| | Bone Marrow Cells | 2 | 2012 | 316 | 0.440 |
Why?
| | Microfluidics | 5 | 2017 | 54 | 0.430 |
Why?
| | Skin | 3 | 2024 | 751 | 0.430 |
Why?
| | Biomedical Engineering | 4 | 2021 | 27 | 0.430 |
Why?
| | Compressive Strength | 6 | 2016 | 73 | 0.430 |
Why?
| | Suspensions | 2 | 2025 | 36 | 0.430 |
Why?
| | Finite Element Analysis | 8 | 2018 | 75 | 0.420 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 179 | 0.420 |
Why?
| | Molecular Structure | 6 | 2013 | 498 | 0.410 |
Why?
| | Nanostructures | 3 | 2015 | 110 | 0.410 |
Why?
| | Rats, Wistar | 7 | 2019 | 455 | 0.410 |
Why?
| | Immunosuppressive Agents | 5 | 2004 | 890 | 0.400 |
Why?
| | Transcription Factors | 4 | 2021 | 1720 | 0.400 |
Why?
| | Bone Substitutes | 2 | 2003 | 27 | 0.400 |
Why?
| | Substantia Nigra | 2 | 2024 | 57 | 0.400 |
Why?
| | Hemodynamics | 5 | 2019 | 1110 | 0.400 |
Why?
| | Time Factors | 17 | 2019 | 6818 | 0.400 |
Why?
| | Proteins | 1 | 2019 | 1012 | 0.400 |
Why?
| | Extracellular Matrix Proteins | 3 | 2013 | 152 | 0.400 |
Why?
| | Wound Healing | 4 | 2023 | 329 | 0.380 |
Why?
| | Stem Cell Niche | 1 | 2012 | 54 | 0.380 |
Why?
| | Nerve Regeneration | 2 | 2009 | 59 | 0.380 |
Why?
| | Myocardial Contraction | 4 | 2018 | 340 | 0.370 |
Why?
| | Calmodulin | 1 | 2011 | 76 | 0.360 |
Why?
| | Computer Simulation | 8 | 2021 | 979 | 0.360 |
Why?
| | Chondroitin Sulfates | 2 | 2009 | 33 | 0.360 |
Why?
| | Aorta | 2 | 2011 | 417 | 0.360 |
Why?
| | Gold | 4 | 2021 | 125 | 0.350 |
Why?
| | Biophysics | 2 | 2022 | 69 | 0.340 |
Why?
| | Mice, Nude | 6 | 2018 | 696 | 0.340 |
Why?
| | Fibrocartilage | 2 | 2025 | 7 | 0.340 |
Why?
| | Hypertrophy | 1 | 2011 | 133 | 0.340 |
Why?
| | Polyesters | 8 | 2009 | 78 | 0.340 |
Why?
| | Sheep | 7 | 2023 | 855 | 0.340 |
Why?
| | Myocytes, Cardiac | 5 | 2021 | 528 | 0.330 |
Why?
| | Male | 43 | 2019 | 67560 | 0.330 |
Why?
| | Hexuronic Acids | 3 | 2016 | 23 | 0.320 |
Why?
| | Membranes, Artificial | 1 | 2010 | 72 | 0.320 |
Why?
| | Glucuronic Acid | 3 | 2016 | 25 | 0.320 |
Why?
| | Ultraviolet Rays | 6 | 2024 | 390 | 0.320 |
Why?
| | Kidney Diseases | 2 | 2013 | 406 | 0.320 |
Why?
| | Immunotherapy | 2 | 2015 | 641 | 0.320 |
Why?
| | Human Umbilical Vein Endothelial Cells | 4 | 2019 | 106 | 0.310 |
Why?
| | Biomimetics | 4 | 2021 | 44 | 0.300 |
Why?
| | Cell- and Tissue-Based Therapy | 3 | 2016 | 82 | 0.300 |
Why?
| | Gelatin | 3 | 2021 | 51 | 0.300 |
Why?
| | Axons | 3 | 2024 | 199 | 0.300 |
Why?
| | Ear Auricle | 1 | 2008 | 10 | 0.290 |
Why?
| | Bioprosthesis | 1 | 2008 | 41 | 0.290 |
Why?
| | Transplantation | 1 | 2008 | 34 | 0.290 |
Why?
| | Myocardial Ischemia | 3 | 2015 | 263 | 0.290 |
Why?
| | Inflammation | 4 | 2016 | 2836 | 0.290 |
Why?
| | Implants, Experimental | 3 | 2013 | 21 | 0.270 |
Why?
| | Molecular Weight | 4 | 2009 | 335 | 0.270 |
Why?
| | Bioengineering | 2 | 2019 | 19 | 0.270 |
Why?
| | Focal Adhesions | 3 | 2018 | 44 | 0.270 |
Why?
| | Doxorubicin | 1 | 2009 | 365 | 0.270 |
Why?
| | Fluorescein-5-isothiocyanate | 3 | 2018 | 35 | 0.270 |
Why?
| | Neurogenesis | 1 | 2009 | 147 | 0.270 |
Why?
| | Mitral Valve Insufficiency | 2 | 2019 | 69 | 0.270 |
Why?
| | Ear Cartilage | 1 | 2006 | 4 | 0.260 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2018 | 123 | 0.260 |
Why?
| | Electrochemistry | 4 | 2011 | 79 | 0.260 |
Why?
| | Anisotropy | 7 | 2025 | 79 | 0.260 |
Why?
| | Waiting Lists | 3 | 2008 | 262 | 0.260 |
Why?
| | Prostheses and Implants | 3 | 2019 | 143 | 0.260 |
Why?
| | Lymphocytes | 2 | 1999 | 395 | 0.260 |
Why?
| | Norbornanes | 3 | 2024 | 15 | 0.250 |
Why?
| | Collagenases | 2 | 2017 | 25 | 0.250 |
Why?
| | Viscosity | 3 | 2018 | 92 | 0.250 |
Why?
| | Endothelium, Vascular | 1 | 2012 | 927 | 0.250 |
Why?
| | Cell Proliferation | 10 | 2019 | 2479 | 0.250 |
Why?
| | Glioblastoma | 2 | 2021 | 343 | 0.250 |
Why?
| | Kinetics | 5 | 2021 | 1674 | 0.250 |
Why?
| | Heart | 3 | 2016 | 657 | 0.250 |
Why?
| | Kidney | 5 | 2025 | 1467 | 0.250 |
Why?
| | Cell Enlargement | 1 | 2005 | 7 | 0.240 |
Why?
| | Growth Substances | 2 | 2003 | 147 | 0.240 |
Why?
| | Drug Compounding | 5 | 2018 | 101 | 0.240 |
Why?
| | Collagen Type V | 1 | 2025 | 4 | 0.240 |
Why?
| | Diastole | 2 | 2016 | 150 | 0.240 |
Why?
| | Neurites | 1 | 2005 | 48 | 0.240 |
Why?
| | Durapatite | 3 | 2014 | 37 | 0.230 |
Why?
| | Temperature | 4 | 2011 | 677 | 0.230 |
Why?
| | 3T3 Cells | 3 | 2018 | 163 | 0.230 |
Why?
| | Alveolar Epithelial Cells | 2 | 2023 | 114 | 0.230 |
Why?
| | Cells, Immobilized | 3 | 2016 | 21 | 0.220 |
Why?
| | Calcification, Physiologic | 2 | 2013 | 32 | 0.220 |
Why?
| | Biomedical Research | 1 | 2011 | 693 | 0.220 |
Why?
| | Flow Cytometry | 3 | 2019 | 1184 | 0.220 |
Why?
| | Emulsions | 2 | 2022 | 54 | 0.220 |
Why?
| | Recovery of Function | 7 | 2019 | 657 | 0.220 |
Why?
| | Elasticity | 4 | 2010 | 197 | 0.220 |
Why?
| | Bone Marrow Transplantation | 2 | 2018 | 287 | 0.220 |
Why?
| | Goats | 1 | 2023 | 27 | 0.220 |
Why?
| | Dopaminergic Neurons | 1 | 2024 | 68 | 0.220 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 3 | 2015 | 191 | 0.220 |
Why?
| | Magnetic Resonance Imaging | 8 | 2016 | 3568 | 0.210 |
Why?
| | Azetidines | 1 | 2024 | 43 | 0.210 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 2022 | 81 | 0.210 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2023 | 22 | 0.210 |
Why?
| | Immunohistochemistry | 5 | 2014 | 1734 | 0.210 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2023 | 33 | 0.210 |
Why?
| | Intervertebral Disc | 1 | 2023 | 39 | 0.210 |
Why?
| | Proteolysis | 2 | 2015 | 178 | 0.210 |
Why?
| | Orthopedics | 2 | 2023 | 155 | 0.210 |
Why?
| | Mycophenolic Acid | 1 | 2004 | 117 | 0.200 |
Why?
| | Glass | 2 | 2016 | 45 | 0.200 |
Why?
| | Butadienes | 1 | 2003 | 36 | 0.200 |
Why?
| | Corpus Striatum | 1 | 2024 | 167 | 0.200 |
Why?
| | Cues | 2 | 2022 | 315 | 0.200 |
Why?
| | Purines | 1 | 2024 | 176 | 0.200 |
Why?
| | Alkaline Phosphatase | 4 | 2013 | 148 | 0.190 |
Why?
| | Technology | 1 | 2023 | 96 | 0.190 |
Why?
| | Recombinant Proteins | 3 | 2018 | 1354 | 0.190 |
Why?
| | Polyhydroxyethyl Methacrylate | 2 | 2013 | 10 | 0.190 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2012 | 52 | 0.190 |
Why?
| | Hydrazones | 1 | 2022 | 25 | 0.190 |
Why?
| | Mice, Inbred BALB C | 4 | 2015 | 1269 | 0.190 |
Why?
| | Hydrazines | 1 | 2022 | 35 | 0.190 |
Why?
| | Thermodynamics | 3 | 2021 | 420 | 0.190 |
Why?
| | Pentoxifylline | 2 | 1999 | 25 | 0.190 |
Why?
| | Baths | 1 | 2021 | 14 | 0.190 |
Why?
| | Models, Biological | 4 | 2018 | 1773 | 0.180 |
Why?
| | Biliary Atresia | 1 | 2023 | 163 | 0.180 |
Why?
| | Neostriatum | 1 | 2021 | 33 | 0.180 |
Why?
| | Aldehydes | 1 | 2022 | 145 | 0.180 |
Why?
| | Green Fluorescent Proteins | 3 | 2018 | 390 | 0.180 |
Why?
| | Models, Animal | 4 | 2021 | 384 | 0.180 |
Why?
| | Nerve Fibers | 1 | 2021 | 96 | 0.180 |
Why?
| | Drug Implants | 2 | 2015 | 82 | 0.170 |
Why?
| | Drug Liberation | 2 | 2018 | 36 | 0.170 |
Why?
| | Aggrecans | 2 | 2011 | 14 | 0.170 |
Why?
| | Collagen Type II | 2 | 2011 | 53 | 0.170 |
Why?
| | Polysaccharides | 1 | 2020 | 84 | 0.170 |
Why?
| | Cyclodextrins | 2 | 2021 | 7 | 0.170 |
Why?
| | Chickens | 2 | 2011 | 191 | 0.170 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 2904 | 0.170 |
Why?
| | Pyrazoles | 1 | 2024 | 423 | 0.170 |
Why?
| | Metal Nanoparticles | 1 | 2021 | 89 | 0.170 |
Why?
| | Apoptosis | 2 | 2013 | 2554 | 0.170 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2021 | 184 | 0.170 |
Why?
| | Fibrosis | 6 | 2020 | 552 | 0.170 |
Why?
| | Cartilage Diseases | 1 | 2020 | 39 | 0.170 |
Why?
| | Disease | 1 | 2021 | 98 | 0.160 |
Why?
| | Sulfonamides | 1 | 2024 | 512 | 0.160 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 81 | 0.160 |
Why?
| | In Vitro Techniques | 3 | 2015 | 1089 | 0.160 |
Why?
| | Acrylates | 2 | 2011 | 47 | 0.160 |
Why?
| | Collagen Type I | 2 | 2011 | 133 | 0.160 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 324 | 0.160 |
Why?
| | Microscopy, Fluorescence | 2 | 2016 | 397 | 0.160 |
Why?
| | Acyltransferases | 2 | 2017 | 56 | 0.160 |
Why?
| | Pyrrolidinones | 1 | 1999 | 29 | 0.160 |
Why?
| | Macrophages | 3 | 2014 | 1544 | 0.160 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1999 | 89 | 0.150 |
Why?
| | Mitral Valve | 1 | 2019 | 89 | 0.150 |
Why?
| | Terminology as Topic | 2 | 2017 | 216 | 0.150 |
Why?
| | Gene Expression Regulation | 4 | 2013 | 2608 | 0.150 |
Why?
| | Anhydrides | 3 | 2005 | 18 | 0.150 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2009 | 152 | 0.150 |
Why?
| | Matrix Metalloproteinases | 2 | 2022 | 94 | 0.150 |
Why?
| | Swine, Miniature | 2 | 2015 | 82 | 0.150 |
Why?
| | Angiogenic Proteins | 1 | 2018 | 16 | 0.150 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2018 | 56 | 0.150 |
Why?
| | Chromatin | 1 | 2022 | 519 | 0.150 |
Why?
| | Dextran Sulfate | 1 | 2018 | 83 | 0.150 |
Why?
| | Drug Synergism | 2 | 2015 | 383 | 0.140 |
Why?
| | Polyglycolic Acid | 4 | 2010 | 43 | 0.140 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 405 | 0.140 |
Why?
| | Isomerism | 1 | 2018 | 56 | 0.140 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2018 | 81 | 0.140 |
Why?
| | Cell Shape | 2 | 2016 | 57 | 0.140 |
Why?
| | Connective Tissue Cells | 1 | 2017 | 2 | 0.140 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2018 | 2052 | 0.140 |
Why?
| | Prions | 1 | 2018 | 48 | 0.140 |
Why?
| | Serum Albumin, Bovine | 1 | 2018 | 64 | 0.140 |
Why?
| | Bioreactors | 2 | 2009 | 46 | 0.140 |
Why?
| | Tacrolimus | 4 | 2004 | 199 | 0.140 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2017 | 91 | 0.140 |
Why?
| | Spectrophotometry, Ultraviolet | 3 | 2009 | 86 | 0.140 |
Why?
| | Stromal Cells | 1 | 2018 | 112 | 0.140 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 2 | 2025 | 17 | 0.140 |
Why?
| | Molecular Probes | 1 | 2017 | 36 | 0.140 |
Why?
| | Rats, Nude | 1 | 2017 | 26 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2019 | 204 | 0.140 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2009 | 616 | 0.140 |
Why?
| | Cell-Derived Microparticles | 1 | 2018 | 71 | 0.130 |
Why?
| | Photolysis | 2 | 2025 | 91 | 0.130 |
Why?
| | Treatment Outcome | 7 | 2015 | 10800 | 0.130 |
Why?
| | Blood Platelets | 1 | 2020 | 407 | 0.130 |
Why?
| | Cyclosporine | 5 | 2004 | 268 | 0.130 |
Why?
| | Amino Acid Sequence | 2 | 2011 | 2147 | 0.130 |
Why?
| | Adenocarcinoma | 2 | 2023 | 939 | 0.130 |
Why?
| | Excitation Contraction Coupling | 1 | 2016 | 17 | 0.130 |
Why?
| | Pericardium | 1 | 2017 | 56 | 0.130 |
Why?
| | Kidney Transplantation | 6 | 2000 | 701 | 0.130 |
Why?
| | Cardiovascular Agents | 1 | 2018 | 160 | 0.130 |
Why?
| | Cell Aggregation | 1 | 2016 | 26 | 0.130 |
Why?
| | Cardiac Volume | 2 | 2017 | 13 | 0.130 |
Why?
| | Hardness | 1 | 2016 | 17 | 0.130 |
Why?
| | Remission, Spontaneous | 1 | 2016 | 40 | 0.130 |
Why?
| | Embryonic Stem Cells | 2 | 2007 | 123 | 0.130 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 219 | 0.130 |
Why?
| | Neurotrophin 3 | 2 | 2006 | 9 | 0.130 |
Why?
| | Bioartificial Organs | 1 | 2016 | 3 | 0.130 |
Why?
| | Heart Conduction System | 1 | 2016 | 101 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 659 | 0.120 |
Why?
| | Adhesiveness | 2 | 2013 | 20 | 0.120 |
Why?
| | Calixarenes | 1 | 2015 | 5 | 0.120 |
Why?
| | Bridged-Ring Compounds | 1 | 2015 | 14 | 0.120 |
Why?
| | Dermis | 1 | 2015 | 33 | 0.120 |
Why?
| | Hindlimb | 2 | 2015 | 128 | 0.120 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2015 | 53 | 0.120 |
Why?
| | Fibrin | 1 | 2016 | 81 | 0.120 |
Why?
| | Gene Transfer Techniques | 1 | 2016 | 169 | 0.120 |
Why?
| | Parkinson Disease | 1 | 2021 | 491 | 0.120 |
Why?
| | Sensation | 1 | 2015 | 53 | 0.120 |
Why?
| | Enzyme Therapy | 1 | 2015 | 4 | 0.120 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 615 | 0.120 |
Why?
| | T-Lymphocytes | 1 | 2004 | 1998 | 0.120 |
Why?
| | Equipment Failure Analysis | 1 | 2015 | 132 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2016 | 188 | 0.120 |
Why?
| | Bridged Bicyclo Compounds | 1 | 2015 | 12 | 0.120 |
Why?
| | Radiography | 2 | 2014 | 832 | 0.120 |
Why?
| | Blood Vessel Prosthesis | 2 | 2013 | 127 | 0.120 |
Why?
| | Phenols | 1 | 2015 | 100 | 0.110 |
Why?
| | Glycosaminoglycans | 2 | 2012 | 84 | 0.110 |
Why?
| | Ventricular Function | 1 | 2014 | 60 | 0.110 |
Why?
| | Spinal Cord | 2 | 2015 | 370 | 0.110 |
Why?
| | Weight-Bearing | 2 | 2013 | 174 | 0.110 |
Why?
| | Menisci, Tibial | 1 | 2015 | 61 | 0.110 |
Why?
| | Immune Tolerance | 1 | 2017 | 362 | 0.110 |
Why?
| | Posture | 1 | 2015 | 186 | 0.110 |
Why?
| | Technology, Pharmaceutical | 1 | 2014 | 30 | 0.110 |
Why?
| | DNA | 3 | 2009 | 1459 | 0.110 |
Why?
| | Fracture Healing | 1 | 2014 | 82 | 0.110 |
Why?
| | Imidazoles | 1 | 2015 | 239 | 0.110 |
Why?
| | Bone Remodeling | 1 | 2014 | 75 | 0.110 |
Why?
| | Lung | 3 | 2023 | 4067 | 0.110 |
Why?
| | RNA-Binding Proteins | 1 | 2018 | 424 | 0.110 |
Why?
| | Injections, Intradermal | 1 | 2013 | 13 | 0.110 |
Why?
| | Cardiomyopathies | 2 | 2017 | 350 | 0.110 |
Why?
| | Neuregulin-1 | 1 | 2014 | 46 | 0.110 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2014 | 106 | 0.110 |
Why?
| | Neovascularization, Pathologic | 1 | 2016 | 301 | 0.110 |
Why?
| | Graft Survival | 5 | 2018 | 534 | 0.110 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 387 | 0.110 |
Why?
| | Solubility | 1 | 2014 | 247 | 0.110 |
Why?
| | Glucocorticoids | 1 | 1998 | 596 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2679 | 0.110 |
Why?
| | Nanoparticles | 2 | 2010 | 484 | 0.100 |
Why?
| | Vinculin | 1 | 2013 | 10 | 0.100 |
Why?
| | Molecular Mimicry | 1 | 2013 | 42 | 0.100 |
Why?
| | Reperfusion Injury | 1 | 2016 | 279 | 0.100 |
Why?
| | Prosthesis Design | 1 | 2015 | 329 | 0.100 |
Why?
| | Osseointegration | 1 | 2013 | 71 | 0.100 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 165 | 0.100 |
Why?
| | Graft Rejection | 5 | 2000 | 620 | 0.100 |
Why?
| | Receptors, Notch | 1 | 2013 | 88 | 0.100 |
Why?
| | Nerve Net | 1 | 2015 | 258 | 0.100 |
Why?
| | PPAR gamma | 1 | 2013 | 182 | 0.100 |
Why?
| | Echocardiography | 2 | 2016 | 659 | 0.100 |
Why?
| | Coculture Techniques | 3 | 2019 | 239 | 0.100 |
Why?
| | Biological Products | 1 | 2016 | 215 | 0.100 |
Why?
| | Static Electricity | 1 | 2012 | 120 | 0.100 |
Why?
| | Cardiac Output | 2 | 2011 | 164 | 0.100 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 480 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2012 | 544 | 0.100 |
Why?
| | Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2011 | 2 | 0.100 |
Why?
| | Calcium-Binding Proteins | 1 | 2013 | 218 | 0.090 |
Why?
| | Methylmethacrylates | 1 | 2011 | 4 | 0.090 |
Why?
| | Transition Temperature | 1 | 2011 | 27 | 0.090 |
Why?
| | P-Selectin | 1 | 2011 | 28 | 0.090 |
Why?
| | Myocardial Reperfusion | 1 | 2011 | 50 | 0.090 |
Why?
| | Parathyroid Hormone-Related Protein | 1 | 2011 | 24 | 0.090 |
Why?
| | Cell Polarity | 1 | 2012 | 141 | 0.090 |
Why?
| | Acrylamides | 1 | 2011 | 57 | 0.090 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 498 | 0.090 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 86 | 0.090 |
Why?
| | Tissue Culture Techniques | 1 | 2011 | 77 | 0.090 |
Why?
| | A Kinase Anchor Proteins | 1 | 2011 | 72 | 0.090 |
Why?
| | Protein Engineering | 1 | 2011 | 109 | 0.090 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 2011 | 52 | 0.090 |
Why?
| | Polymerization | 1 | 2011 | 126 | 0.080 |
Why?
| | Microvessels | 1 | 2011 | 85 | 0.080 |
Why?
| | Micelles | 1 | 2010 | 40 | 0.080 |
Why?
| | Models, Chemical | 2 | 2002 | 268 | 0.080 |
Why?
| | Glycolates | 2 | 2010 | 4 | 0.080 |
Why?
| | Pressure | 1 | 2010 | 222 | 0.080 |
Why?
| | Cell Division | 2 | 2004 | 796 | 0.080 |
Why?
| | Molecular Conformation | 1 | 2010 | 150 | 0.080 |
Why?
| | Coronary Vessels | 1 | 2011 | 246 | 0.080 |
Why?
| | Chitosan | 2 | 2007 | 34 | 0.080 |
Why?
| | Macromolecular Substances | 1 | 2010 | 229 | 0.080 |
Why?
| | Ethylene Glycols | 1 | 2009 | 16 | 0.080 |
Why?
| | Microscopy | 1 | 2010 | 144 | 0.080 |
Why?
| | High-Throughput Screening Assays | 1 | 2011 | 160 | 0.080 |
Why?
| | Morphogenesis | 2 | 2025 | 166 | 0.080 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2009 | 13 | 0.080 |
Why?
| | Absorption | 1 | 2009 | 63 | 0.080 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2009 | 77 | 0.080 |
Why?
| | Methylprednisolone | 2 | 1999 | 85 | 0.070 |
Why?
| | Lactates | 2 | 2005 | 85 | 0.070 |
Why?
| | Peripheral Nerves | 1 | 2009 | 65 | 0.070 |
Why?
| | Mesoderm | 1 | 2009 | 144 | 0.070 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 612 | 0.070 |
Why?
| | Surface-Active Agents | 1 | 2009 | 91 | 0.070 |
Why?
| | Pyrroles | 1 | 2009 | 213 | 0.070 |
Why?
| | Sheep, Domestic | 2 | 2019 | 34 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2113 | 0.070 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2008 | 8 | 0.070 |
Why?
| | Metals | 1 | 2009 | 137 | 0.070 |
Why?
| | Liposomes | 1 | 2010 | 220 | 0.070 |
Why?
| | Asia | 1 | 2008 | 70 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 858 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2016 | 811 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3414 | 0.070 |
Why?
| | Microscopy, Confocal | 2 | 2014 | 324 | 0.070 |
Why?
| | Adult | 11 | 2021 | 37724 | 0.070 |
Why?
| | Propylene Glycols | 1 | 2007 | 28 | 0.070 |
Why?
| | Hydrolysis | 1 | 2008 | 192 | 0.070 |
Why?
| | Immunoenzyme Techniques | 1 | 2008 | 219 | 0.070 |
Why?
| | Organ Specificity | 1 | 2008 | 304 | 0.070 |
Why?
| | Equipment Design | 1 | 2009 | 522 | 0.070 |
Why?
| | Geography | 1 | 2008 | 198 | 0.070 |
Why?
| | Travel | 1 | 2008 | 129 | 0.070 |
Why?
| | Muscle Cells | 1 | 2007 | 43 | 0.070 |
Why?
| | Ventricular Pressure | 2 | 2018 | 48 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2016 | 159 | 0.070 |
Why?
| | Phenotype | 4 | 2025 | 3202 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2013 | 1163 | 0.070 |
Why?
| | Neurons | 3 | 2021 | 1588 | 0.060 |
Why?
| | Ligands | 2 | 2021 | 664 | 0.060 |
Why?
| | Bone Marrow | 1 | 2008 | 286 | 0.060 |
Why?
| | Cell Count | 3 | 2013 | 323 | 0.060 |
Why?
| | Leukocytes, Mononuclear | 2 | 2018 | 558 | 0.060 |
Why?
| | Adipates | 1 | 2005 | 2 | 0.060 |
Why?
| | Hot Temperature | 1 | 2009 | 394 | 0.060 |
Why?
| | Decanoic Acids | 1 | 2005 | 8 | 0.060 |
Why?
| | Ethylamines | 1 | 2005 | 5 | 0.060 |
Why?
| | Ciliary Neurotrophic Factor | 1 | 2005 | 12 | 0.060 |
Why?
| | Muscles | 2 | 2001 | 325 | 0.060 |
Why?
| | Tissue and Organ Procurement | 2 | 2008 | 314 | 0.060 |
Why?
| | Erythroblasts | 1 | 2005 | 19 | 0.060 |
Why?
| | Lipids | 1 | 2010 | 666 | 0.060 |
Why?
| | Animals, Newborn | 2 | 2014 | 844 | 0.060 |
Why?
| | Polyanhydrides | 1 | 2005 | 2 | 0.060 |
Why?
| | Carbohydrate Sequence | 1 | 2005 | 27 | 0.060 |
Why?
| | Cohort Studies | 2 | 2010 | 5726 | 0.060 |
Why?
| | Organogenesis | 1 | 2025 | 58 | 0.060 |
Why?
| | Cardiac Surgical Procedures | 1 | 2010 | 530 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2018 | 731 | 0.060 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2005 | 133 | 0.060 |
Why?
| | Lab-On-A-Chip Devices | 1 | 2024 | 40 | 0.060 |
Why?
| | Nucleus Pulposus | 1 | 2023 | 1 | 0.050 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 26 | 0.050 |
Why?
| | Spectrometry, Fluorescence | 1 | 2004 | 168 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2021 | 2164 | 0.050 |
Why?
| | Transcriptome | 2 | 2021 | 972 | 0.050 |
Why?
| | Bilirubin | 1 | 2023 | 97 | 0.050 |
Why?
| | Myoblasts | 1 | 2023 | 84 | 0.050 |
Why?
| | Cell Separation | 1 | 2004 | 318 | 0.050 |
Why?
| | Retina | 1 | 2005 | 298 | 0.050 |
Why?
| | Psoriasis | 1 | 2024 | 102 | 0.050 |
Why?
| | Chromatography, Gel | 1 | 2003 | 127 | 0.050 |
Why?
| | Biosensing Techniques | 1 | 2004 | 126 | 0.050 |
Why?
| | Tissue Donors | 2 | 1997 | 417 | 0.050 |
Why?
| | Spinal Cord Injuries | 1 | 2006 | 212 | 0.050 |
Why?
| | Connective Tissue | 1 | 2022 | 36 | 0.050 |
Why?
| | Perfusion | 1 | 2023 | 211 | 0.050 |
Why?
| | Rabbits | 1 | 2023 | 793 | 0.050 |
Why?
| | Theranostic Nanomedicine | 1 | 2022 | 15 | 0.050 |
Why?
| | Respiration | 1 | 2023 | 198 | 0.050 |
Why?
| | Subcutaneous Tissue | 1 | 2002 | 24 | 0.050 |
Why?
| | Sirolimus | 1 | 2004 | 275 | 0.050 |
Why?
| | Tendons | 1 | 2023 | 110 | 0.050 |
Why?
| | Liver Transplantation | 3 | 1995 | 871 | 0.050 |
Why?
| | Cholic Acid | 1 | 2021 | 5 | 0.050 |
Why?
| | Dopamine | 1 | 2024 | 303 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2003 | 574 | 0.050 |
Why?
| | Aspergillus fumigatus | 1 | 2001 | 26 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2022 | 188 | 0.040 |
Why?
| | Photochemotherapy | 1 | 2001 | 37 | 0.040 |
Why?
| | Cell Cycle Proteins | 2 | 2017 | 613 | 0.040 |
Why?
| | Chlorobenzenes | 1 | 2001 | 9 | 0.040 |
Why?
| | Succinimides | 1 | 2001 | 19 | 0.040 |
Why?
| | Fluorescent Dyes | 2 | 2015 | 318 | 0.040 |
Why?
| | Polystyrenes | 1 | 2001 | 36 | 0.040 |
Why?
| | Plasmapheresis | 1 | 2000 | 24 | 0.040 |
Why?
| | Optical Imaging | 1 | 2021 | 61 | 0.040 |
Why?
| | Contrast Media | 1 | 2023 | 462 | 0.040 |
Why?
| | Cell Engineering | 1 | 2020 | 13 | 0.040 |
Why?
| | Nuclear Envelope | 1 | 2021 | 39 | 0.040 |
Why?
| | Adsorption | 1 | 2001 | 151 | 0.040 |
Why?
| | Kidney Glomerulus | 2 | 1998 | 114 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2020 | 94 | 0.040 |
Why?
| | Epigenomics | 1 | 2021 | 115 | 0.040 |
Why?
| | Cryopreservation | 1 | 2021 | 98 | 0.040 |
Why?
| | Fibronectins | 1 | 2020 | 133 | 0.040 |
Why?
| | Registries | 1 | 2008 | 2016 | 0.040 |
Why?
| | Rolipram | 1 | 1999 | 3 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2000 | 132 | 0.040 |
Why?
| | Tritium | 1 | 1999 | 76 | 0.040 |
Why?
| | Thymidine | 1 | 1999 | 60 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2004 | 1150 | 0.040 |
Why?
| | Neural Pathways | 1 | 2021 | 295 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 524 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 674 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 238 | 0.040 |
Why?
| | Nephrectomy | 1 | 2000 | 168 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2016 | 5753 | 0.040 |
Why?
| | Cathelicidins | 1 | 2018 | 41 | 0.040 |
Why?
| | Biopsy | 3 | 2016 | 1127 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 806 | 0.040 |
Why?
| | Female | 12 | 2024 | 73052 | 0.040 |
Why?
| | beta Karyopherins | 1 | 2018 | 8 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2019 | 226 | 0.040 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2018 | 18 | 0.040 |
Why?
| | RNA-Binding Protein EWS | 1 | 2018 | 26 | 0.040 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 1998 | 47 | 0.040 |
Why?
| | Karyopherins | 1 | 2018 | 18 | 0.040 |
Why?
| | Prednisolone | 1 | 1998 | 83 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 311 | 0.040 |
Why?
| | Cell Size | 1 | 2018 | 91 | 0.040 |
Why?
| | Paracrine Communication | 1 | 2018 | 65 | 0.040 |
Why?
| | Systole | 1 | 2018 | 191 | 0.040 |
Why?
| | Living Donors | 1 | 2000 | 295 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2018 | 147 | 0.030 |
Why?
| | Middle Aged | 8 | 2018 | 33310 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 2017 | 77 | 0.030 |
Why?
| | Stress Fibers | 1 | 2017 | 19 | 0.030 |
Why?
| | Integrins | 1 | 2018 | 95 | 0.030 |
Why?
| | Cytoplasm | 1 | 2018 | 272 | 0.030 |
Why?
| | Actomyosin | 1 | 2017 | 18 | 0.030 |
Why?
| | Biophysical Phenomena | 1 | 2017 | 64 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 752 | 0.030 |
Why?
| | Histones | 1 | 2022 | 636 | 0.030 |
Why?
| | Health Care Rationing | 1 | 1997 | 59 | 0.030 |
Why?
| | Protein Domains | 1 | 2018 | 290 | 0.030 |
Why?
| | HeLa Cells | 1 | 2018 | 637 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 2018 | 195 | 0.030 |
Why?
| | Sus scrofa | 1 | 2016 | 52 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2019 | 514 | 0.030 |
Why?
| | Drosophila melanogaster | 1 | 2018 | 233 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 136 | 0.030 |
Why?
| | Aged | 4 | 2018 | 23851 | 0.030 |
Why?
| | Interferon-gamma | 1 | 1999 | 790 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 231 | 0.030 |
Why?
| | Acidosis, Renal Tubular | 1 | 1995 | 4 | 0.030 |
Why?
| | Lipocalin-2 | 1 | 2016 | 79 | 0.030 |
Why?
| | Laparoscopy | 1 | 2000 | 464 | 0.030 |
Why?
| | Oxazines | 1 | 2015 | 30 | 0.030 |
Why?
| | Capsules | 1 | 2015 | 38 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2015 | 171 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1998 | 1318 | 0.030 |
Why?
| | Dextrans | 1 | 2015 | 84 | 0.030 |
Why?
| | Databases, Factual | 1 | 2001 | 1355 | 0.030 |
Why?
| | Injections, Intralesional | 1 | 2014 | 34 | 0.030 |
Why?
| | Epidermis | 1 | 2015 | 157 | 0.030 |
Why?
| | Trans-Activators | 1 | 2017 | 398 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1058 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 109 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2015 | 269 | 0.030 |
Why?
| | Kidney Tubules, Proximal | 1 | 1995 | 127 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 455 | 0.030 |
Why?
| | Venous Cutdown | 1 | 1994 | 1 | 0.030 |
Why?
| | Homeostasis | 1 | 2018 | 619 | 0.030 |
Why?
| | Behavior, Animal | 2 | 2009 | 497 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2015 | 564 | 0.030 |
Why?
| | Serrate-Jagged Proteins | 1 | 2013 | 27 | 0.030 |
Why?
| | Jagged-1 Protein | 1 | 2013 | 23 | 0.030 |
Why?
| | Immobilized Proteins | 1 | 2013 | 10 | 0.030 |
Why?
| | Random Allocation | 1 | 2014 | 353 | 0.030 |
Why?
| | Catheters, Indwelling | 1 | 1994 | 92 | 0.030 |
Why?
| | Attitude to Health | 1 | 1997 | 440 | 0.030 |
Why?
| | Stroke Volume | 1 | 2016 | 619 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 91 | 0.030 |
Why?
| | Cardiac Catheterization | 1 | 2016 | 528 | 0.020 |
Why?
| | Fluoresceins | 1 | 2012 | 47 | 0.020 |
Why?
| | Lactones | 1 | 2012 | 56 | 0.020 |
Why?
| | Creatinine | 3 | 2000 | 499 | 0.020 |
Why?
| | L-Selectin | 1 | 2011 | 26 | 0.020 |
Why?
| | Diffusion | 1 | 2012 | 119 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1456 | 0.020 |
Why?
| | Blood Pressure | 2 | 2016 | 1776 | 0.020 |
Why?
| | Fluorescence | 1 | 2012 | 160 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2016 | 778 | 0.020 |
Why?
| | Synapses | 1 | 2015 | 427 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 242 | 0.020 |
Why?
| | Cyclosporins | 1 | 1991 | 76 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1774 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2011 | 141 | 0.020 |
Why?
| | Transplantation, Autologous | 1 | 2011 | 238 | 0.020 |
Why?
| | United States | 1 | 2008 | 14742 | 0.020 |
Why?
| | Hepatitis B | 1 | 1991 | 70 | 0.020 |
Why?
| | Surgical Mesh | 1 | 2010 | 47 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 1501 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2011 | 319 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 4164 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2752 | 0.020 |
Why?
| | Postoperative Complications | 2 | 2000 | 2658 | 0.020 |
Why?
| | Electric Conductivity | 1 | 2009 | 88 | 0.020 |
Why?
| | Fluorescein | 1 | 2009 | 25 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 2009 | 58 | 0.020 |
Why?
| | Sepharose | 1 | 2009 | 34 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2011 | 285 | 0.020 |
Why?
| | Histocompatibility Testing | 2 | 2000 | 126 | 0.020 |
Why?
| | Fetal Blood | 1 | 2011 | 327 | 0.020 |
Why?
| | Biological Assay | 1 | 2009 | 123 | 0.020 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2011 | 389 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 2011 | 402 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 846 | 0.020 |
Why?
| | Pregnancy Complications, Infectious | 1 | 1991 | 389 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 167 | 0.020 |
Why?
| | Mutation | 1 | 2018 | 3956 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2006 | 32 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2006 | 94 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2007 | 155 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2006 | 100 | 0.020 |
Why?
| | Hypertension | 1 | 1995 | 1285 | 0.020 |
Why?
| | Acute Disease | 2 | 2000 | 1009 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1709 | 0.010 |
Why?
| | Child | 2 | 2023 | 21999 | 0.010 |
Why?
| | Neuroglia | 1 | 2006 | 173 | 0.010 |
Why?
| | Actins | 1 | 2007 | 416 | 0.010 |
Why?
| | Body Fluids | 1 | 2005 | 66 | 0.010 |
Why?
| | Laminin | 1 | 2004 | 72 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2004 | 226 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2004 | 232 | 0.010 |
Why?
| | Particle Size | 1 | 2005 | 394 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3283 | 0.010 |
Why?
| | Sequence Tagged Sites | 1 | 2001 | 5 | 0.010 |
Why?
| | Motor Activity | 1 | 2006 | 719 | 0.010 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2001 | 19 | 0.010 |
Why?
| | Information Services | 1 | 2001 | 49 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2004 | 707 | 0.010 |
Why?
| | Antibody Specificity | 1 | 2000 | 189 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 536 | 0.010 |
Why?
| | Antibody Formation | 1 | 2000 | 298 | 0.010 |
Why?
| | Antibodies | 1 | 2000 | 412 | 0.010 |
Why?
| | Cytokines | 1 | 2006 | 2090 | 0.010 |
Why?
| | Bone and Bones | 1 | 2000 | 316 | 0.010 |
Why?
| | Follow-Up Studies | 2 | 1998 | 5125 | 0.010 |
Why?
| | Survival Analysis | 1 | 2000 | 1321 | 0.010 |
Why?
| | Thrombosis | 1 | 2000 | 368 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1996 | 180 | 0.010 |
Why?
| | Lymphoproliferative Disorders | 1 | 1996 | 55 | 0.010 |
Why?
| | Internet | 1 | 2001 | 651 | 0.010 |
Why?
| | Telephone | 1 | 1997 | 171 | 0.010 |
Why?
| | Drug Resistance | 1 | 1996 | 169 | 0.010 |
Why?
| | Cadaver | 1 | 1997 | 297 | 0.010 |
Why?
| | Diarrhea, Infantile | 1 | 1995 | 8 | 0.010 |
Why?
| | Blood Urea Nitrogen | 1 | 1995 | 54 | 0.010 |
Why?
| | Bicarbonates | 1 | 1995 | 44 | 0.010 |
Why?
| | Reperfusion | 1 | 1995 | 40 | 0.010 |
Why?
| | Cytomegalovirus Infections | 1 | 1996 | 191 | 0.010 |
Why?
| | Atrophy | 1 | 1995 | 184 | 0.010 |
Why?
| | Oxygenators | 1 | 1994 | 4 | 0.010 |
Why?
| | Axillary Vein | 1 | 1994 | 4 | 0.010 |
Why?
| | Central Venous Pressure | 1 | 1994 | 14 | 0.010 |
Why?
| | Subclavian Vein | 1 | 1994 | 15 | 0.010 |
Why?
| | Fluid Therapy | 1 | 1995 | 147 | 0.010 |
Why?
| | Kidney Tubules | 1 | 1995 | 117 | 0.010 |
Why?
| | Hepatic Artery | 1 | 1994 | 61 | 0.010 |
Why?
| | Jugular Veins | 1 | 1994 | 42 | 0.010 |
Why?
| | Femoral Vein | 1 | 1994 | 34 | 0.010 |
Why?
| | Triazines | 1 | 1974 | 43 | 0.010 |
Why?
| | Veins | 1 | 1994 | 62 | 0.010 |
Why?
| | Elbow | 1 | 1994 | 56 | 0.010 |
Why?
| | Interviews as Topic | 1 | 1997 | 770 | 0.010 |
Why?
| | Vena Cava, Inferior | 1 | 1994 | 71 | 0.010 |
Why?
| | Incidence | 1 | 2000 | 2808 | 0.010 |
Why?
| | Administration, Oral | 1 | 1995 | 812 | 0.010 |
Why?
| | Patient Selection | 1 | 1997 | 692 | 0.010 |
Why?
| | Portal Vein | 1 | 1994 | 119 | 0.010 |
Why?
| | Catheterization, Central Venous | 1 | 1994 | 111 | 0.010 |
Why?
| | Health Status | 1 | 1997 | 789 | 0.010 |
Why?
| | Transplantation, Isogeneic | 1 | 1991 | 17 | 0.010 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1991 | 50 | 0.010 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 1991 | 41 | 0.010 |
Why?
| | Rats, Inbred BN | 1 | 1991 | 58 | 0.010 |
Why?
| | Blood Transfusion | 1 | 1994 | 326 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 1991 | 114 | 0.010 |
Why?
| | Major Histocompatibility Complex | 1 | 1991 | 227 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2000 | 15639 | 0.010 |
Why?
| | Heart Rate | 1 | 1994 | 823 | 0.010 |
Why?
| | Kidney Neoplasms | 1 | 1974 | 401 | 0.000 |
Why?
| | Prevalence | 1 | 1995 | 2715 | 0.000 |
Why?
| | Anesthesia | 1 | 1991 | 192 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1995 | 2850 | 0.000 |
Why?
| | Risk Factors | 1 | 2000 | 10368 | 0.000 |
Why?
| | Quality of Life | 1 | 1997 | 2885 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1974 | 2135 | 0.000 |
Why?
| | Infant | 1 | 1995 | 9451 | 0.000 |
Why?
| | Adolescent | 1 | 1998 | 21499 | 0.000 |
Why?
| | Pregnancy | 1 | 1991 | 6743 | 0.000 |
Why?
| | Dimethylamines | 1 | 1974 | 4 | 0.000 |
Why?
| | Neoplasm Transplantation | 1 | 1974 | 257 | 0.000 |
Why?
| | Transplantation, Homologous | 1 | 1974 | 415 | 0.000 |
Why?
|
|
Burdick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|